GMO US Value ETF (GMOV)

The GMO US Value ETF (GMOV) is a passive exchange-traded fund that holds a diversified basket of American-listed companies selected according to systematic value criteria — cheap stocks with solid fundamentals, rebalanced on a predictable schedule to lock in contrarian discipline.

What exactly does this fund hold?

GMOV tracks an index composed of stocks from the US market, filtered and weighted to concentrate on value characteristics. The index universe begins with all US companies that meet basic liquidity and listing requirements, then applies a screening process that identifies names trading at discounts to various fundamental measures. The screens look for low price-to-earnings ratios, low price-to-book ratios, low price-to-cash-flow ratios, and high dividend yields — the classic hallmarks of cheap stocks. Simultaneously, quality filters ensure that “cheap” does not mean “broken”: companies with deteriorating earnings, weak balance sheets, or unsustainable dividends are excluded, on the premise that truly valuable opportunities come from temporarily out-of-favor but fundamentally sound businesses, not from value traps.

The resulting universe of stocks is typically weighted not by market capitalization (which would overweight the largest companies, whether cheap or expensive) but according to a composite value score. This means the fund may hold 200–300 stocks, with the highest weightings concentrated in the names that score highest on the value metrics. The index is reconstituted semi-annually, forcing the fund to mechanically “rebalance” — selling winners that have appreciated out of value territory and buying fresh candidates that have fallen into it. This buy-cheap, sell-expensive discipline is the opposite of momentum investing and requires the conviction that prices mean-revert over reasonable timeframes.

How does it differ from a simple value index?

Most broad US stock indexes are capitalization-weighted, meaning they automatically tilt toward the largest, most expensive companies. The S&P 500, for instance, includes value stocks but also has huge weightings in megacap growth companies that trade at premium valuations. GMOV explicitly screens and weights to overweight value and underweight growth, creating a portfolio that looks quite different from the overall market.

The mechanical rebalancing schedule is also distinctive. Market-cap-weighted indexes rebalance themselves as prices move — a company that rises in value automatically gets a larger weight. Value indexes, by contrast, are rebalanced on a fixed schedule (often semi-annually), which means the fund actively buys what has gone down and sells what has gone up. It is a form of forced contrarianism, and it works well during periods when mean reversion is active, but it can lag substantially during long bull markets for growth and expensive stocks.

What are the costs and trading mechanics?

GMOV trades on the NASDAQ with tight spreads and ample volume, making it straightforward to buy or sell at transparent intraday prices. The expense ratio is low, reflecting the fund’s passive structure and the systematic, mechanical nature of the index methodology. Annual turnover is moderate — semi-annual reconstitution plus dividend-driven rebalancing — so the fund is tax-efficient relative to more actively managed value strategies.

Distributions come primarily from dividends paid by the underlying stocks, which means GMOV often yields more than the broad market. There are no special tax advantages; shareholders receive standard equity taxation on both dividends and capital gains.

When does a value-focused fund struggle?

Value as a factor underperforms during extended periods when investors favor growth and expensive stocks over cheap ones. From 2016 to 2019 and again from 2020 to 2021, value-tilted strategies significantly lagged the overall market because technology and other high-growth sectors were crushing it. A holder of GMOV during those periods experienced real frustration: the fundamentals looked sound, the valuation discount was genuine, but the price momentum was negative. This is not a temporary volatility hiccup but a genuine risk — that the value premium does not materialize for years at a stretch.

Currency risk is irrelevant here since the fund holds only US-listed companies and US earnings. But sector concentration is a real consideration: value characteristics cluster in certain sectors (energy, financials, industrials) more than others (technology, healthcare), so the fund will overweight those sectors and underweight others, creating bets on sector rotation that may or may not pay off.

How should you research GMOV?

Start by examining the fund’s holdings and comparing them to the broad market. Which sectors dominate? What are the average valuations compared to the S&P 500? The fact sheet and prospectus reveal this directly. Then, look at historical rolling returns — not just year-to-date performance but three-year, five-year, and ten-year periods — to see how the fund has fared during both value outperformance and underperformance phases. Understanding the value premium over full market cycles helps distinguish between genuine underperformance (a real risk worth acknowledging) and a temporary drawdown (a cost of the strategy).

The underlying index methodology document, available from the fund sponsor, explains the exact valuation screens and weighting scheme, which matters because different value definitions can yield quite different portfolios. Compare GMOV’s holdings and performance to other value-focused ETFs to sense-check whether this particular implementation is holding up as expected.